← Stocks · ALZN page
Price chart & company basics · Trifecta Signals
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
The Trifecta List
Alzamend has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.
That’s the whole record for this stock: the chart and the basics above, and nothing to grade.
The list is the public track record: every stock that has signaled, logged, confirmed, and graded.
Alzamend Neuro is a listed company whose shares trade under the ALZN ticker.
Over the past year the shares have traded between $0.86 and $2.55, and the latest close sits in the middle of that range. The low-to-high span over the year comes to about 197%. Price history on this page reaches back to June 2021.
At the most recent close, Thursday, November 5, the shares finished at $1.55, up 1.3% on the day. Over the past week, the shares have traded in a range between about $1.21 and $1.55.
